3 results about "Gemfibrozil" patented technology

The invention provides a preparation method of a key intermediate of a gemfibrozil impurity A, and belongs to the technical field of chemical synthesis. According to the invention, a brand-new synthetic route of the gemfibrozil impurity A is designed firstly, and efficient preparation methods of three key intermediates are provided on the basis of the brand-new synthetic route. Specifically, the preparation method comprises the following steps: firstly, reacting with propionyl chloride in a 1, 2-dichloroethane environment under the catalysis of aluminum trichloride, and cooling, layering and drying a product to obtain a first intermediate; taking the first intermediate as a raw material, reacting with benzyl bromide in a DMF (Dimethyl Formamide) environment by taking potassium carbonate as an acid-binding agent, collecting an organic phase, dissolving with methanol, carrying out reduction reaction by using sodium borohydride under the catalysis of cerium chloride heptahydrate, and collecting to obtain a second intermediate; taking the second intermediate as a raw material, dissolving the second intermediate in methylbenzene, and performing dehydration reaction under the catalysis of TsOH.H2O to obtain a third intermediate; on the basis of the three intermediates, efficient synthesis of the gemfibrozil impurity A can be achieved, the synthesis route is short, and the process efficiency is high.

In an aspect, the disclosure relates to a liquid pharmaceutical composition comprising, consisting essentially of, or consisting of gemfibrozil and an aqueous solvent. The disclosure also relates to methods of making the liquid pharmaceutical composition comprising gemfibrozil, uses thereof, and methods of treatment comprising administering the liquid pharmaceutical composition comprising gemfibrozil.

The application discloses a gemfibrozil deuterated derivative as shown in formula (I) and a preparation method and application thereof, and belongs to the field of organic and pharmaceutical synthesis. The method has simple preparation process and low cost. The gemfibrozil deuterated derivative synthesized by the method has the advantages of high purity and high deuterium substitution rate. The application also discloses application of the gemfibrozil deuterated derivative in treatment of hyperlipidemia. The gemfibrozil deuterated derivative has significantly improved pharmacological effect and significantly reduced toxic metabolites.